Ces2022, Neurotechnology, Neuromodulation, Healthtech.
that assess nerve activity and heart rhythm using a six-lead electrocardiogram (ECG). The company said its investigational device is expected to be available in the second half of 2022, pending FDA clearance and CE marking…CEO Mathieu Letombe remarked that “with Body Scan, we will turn the morning